Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2025 ,inter alia, to consider and approve the Audited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samsrita Labs Ltd (formerly known as Dr Habeebullah Life Sciences Limited) has informed the exchanges that its Board of Directors will meet on Saturday, 26 April 2025 at 3:30 p.m. at the registered office in Hyderabad. The main agenda is to consider and approve the audited financial results along with the audit report for the quarter and financial year ended 31 March 2025. The meeting also includes a standard 'any other business with the permission of the Chair' clause. The intimation was signed by K.N.V. Narendra Kumar, Whole-time Director & CFO, and filed with both BSE (Scrip Code: 539267) and the Metropolitan Stock Exchange (Symbol: SAMSRITA).
This is a routine pre-results intimation with no financial figures disclosed yet. Investors should watch for the actual audited FY25 results, which will be released after the board meeting on 26 April, to assess the company's full-year performance.